Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...

UNAIDS urges speed and compassion urging pharmaceutical companies to enable access to new, life-saving medicinesDAVOS/GENEVA, ...

Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, ...

In addition to having more space and privacy for patients, Ireland said the new location presents a chance for the HOPE ...

Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...

According to “HIV/AIDS in Palestine ... the strike after 125 days and resume taking their medication was when they gave up believing the New York Theatre Workshop would speak out.

Already, the Global Fund to Fight AIDS has joined hands with several ... There are indications that the drug can also prevent new HIV infections. In October this year, Gilead announced that ...

Donkor’s story, and the plight of LGBTQIA+ individuals battling HIV, is one of many stories highlighted in the new Joint United Nations Programme on HIV/AIDS (UNAIDS) report titled “Take The ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...

The HIV epidemic continues to disproportionately affect major urban centers across the United States, with southern cities ...

NEW DELHI: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six ...